News Release

<< Back

Sunesis to Present at Upcoming Investor Conferences


SOUTH SAN FRANCISCO, Calif., Aug. 27, 2012 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the Company will present at two upcoming investor conferences.

Eric Bjerkholt, Executive Vice President, Corporate Development and Finance at Sunesis will present at the Stifel Nicolaus 2012 Healthcare Conference on Thursday, September 6th at 8:00 AM Eastern Time at The Four Seasons Hotel in Boston.

Daniel Swisher, Chief Executive Officer of Sunesis, will present at BioCentury's 19th Annual NewsMakers in the Biotech Industry Conference on Friday, September 7th at 9:00 AM Eastern Time at The Millennium Broadway Hotel & Conference Center in New York City.

A live webcast of the presentations will be available on the Sunesis website at A replay of the webcasts will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks following the presentation.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.

The Sunesis Pharmaceuticals, Inc. logo is available at

CONTACT: Investor and Media Inquiries:
         David PittsArgot Partners

         Eric Bjerkholt
         Sunesis Pharmaceuticals Inc.

Sunesis Pharmaceuticals, Inc. Logo

Sunesis Pharmaceuticals, Inc.